Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.67 |
| ▸ | MAOB | P27338 | 1/20 | 0.67 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.54 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.54 |
| ▸ | FER | P16591 | 1/20 | 0.54 |
| ▸ | LTK | P29376 | 1/20 | 0.54 |
| ▸ | CDK8 | P49336 | 1/20 | 0.54 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.54 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 9/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indigo SCHEMBL42280 | 1.00 | MAOA (0.67) | MAOAMAOBLRRK2PDGFRAFER | |
| Indigo SCHEMBL29829264 | 1.00 | MAOA (0.67) | MAOAMAOBLRRK2PDGFRAFER | |
| Indigo SCHEMBL29583322 | 1.00 | MAOA (0.67) | MAOAMAOBLRRK2PDGFRAFER | |
| Indigo SCHEMBL56085 | 1.00 | MAOA (0.67) | MAOAMAOBLRRK2PDGFRAFER | |
| Indirubin SCHEMBL31032717 | 0.83 | MAOA (0.64) | MAOAMAOBLRRK2PDGFRAFER | |
| Indirubin SCHEMBL9899338 | 0.83 | MAOA (0.64) | MAOAMAOBLRRK2PDGFRAFER | |
| Indirubin SCHEMBL30215500 | 0.83 | MAOA (0.64) | MAOAMAOBLRRK2PDGFRAFER | |
| Indirubin SCHEMBL27678 | 0.83 | MAOA (0.64) | MAOAMAOBLRRK2PDGFRAFER | |
| Indirubin SCHEMBL20535353 | 0.83 | MAOA (0.64) | MAOAMAOBLRRK2PDGFRAFER | |
| Indirubin SCHEMBL6809175 | 0.83 | MAOA (0.64) | MAOAMAOBLRRK2PDGFRAFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240076499-A1 | PROCESS FOR THE PREPARATION OF INDIGOTINDISULFONATE SODIUM (INDIGO CARMINE) | PROVEPHARM LIFE SOLUTIONS S.A. (FR) | 2024-03-07 | — | — | US | claimed |
| US-10927258-B2 | Process for the preparation of Indigotindisulfonate sodium (indigo carmine) | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2021-02-23 | — | — | US | claimed |
| EP-3559121-A1 | NOVEL PROCESS FOR THE PREPARATION OF INDIGOTINDISULFONATE SODIUM (INDIGO CARMINE) | Biophore India Pharmaceuticals Pvt. Ltd. (IN) | 2019-10-30 | — | — | EP | claimed |
| WO-2018116325-A1 | NOVEL PROCESS FOR THE PREPARATION OF INDIGOTINDISULFONATE SODIUM (INDIGO CARMINE) | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2018-06-28 | — | — | WO | claimed |
| JP-4750804-B2 | — | — | 2011-08-17 | — | — | JP | claimed |
| US-20080306026-A1 | Capsule Formulation | SYNGENTA CROP PROTECTION LLC | 2008-12-11 | — | — | US | claimed |
| JP-2008531514-A | — | — | 2008-08-14 | — | — | JP | claimed |
| EP-1850664-A2 | PESTICIDAL CAPSULE FORMULATION | Syngeta Participations AG (CH) | 2007-11-07 | — | — | EP | claimed |
| WO-2006089747-A2 | PRESTICIDAL CAPSULE FORMULATION | SYNGENTA PARTICIPATIONS AG (CH) | 2006-08-31 | — | — | WO | claimed |
| US-20250213444-A1 | COMPOSITION FOR ENHANCING KERATIN FIBERS | WELLA GERMANY GMBH (DE) | 2025-07-03 | — | — | US | disclosed |
| EP-4574216-A2 | COMPOSITION FOR ENHANCING KERATIN FIBERS | Wella Germany GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-20240415751-A1 | WATER REDUCED COMPACT SHAMPOO COMPOSITION | WELLA GERMANY GMBH (DE) | 2024-12-19 | — | — | US | disclosed |
| US-20240415750-A1 | WATER REDUCED COMPACT CONDITIONER COMPOSITION | WELLA GERMANY GMBH (DE) | 2024-12-19 | — | — | US | disclosed |
| CN-112384225-B | Application of edible azo dye brilliant black BN in inhibiting infectivity of human enteroviruses causing hand-foot-mouth disease | 淡马锡生命科学实验室有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-5643356-A | UNSATURATED KETONE SENSITIZER BONDED TO RADIATION TRANSORBER WITH COLOR, MOLECULAR INCLUDENT AND VEHICLES | KIMBERLY-CLARK CORPORATION (US) | 1997-07-01 | — | — | US | disclosed |
| US-5643701-A | Electrophotgraphic process utilizing mutable colored composition | KIMBERLY-CLARK CORPORATION (US) | 1997-07-01 | — | — | US | disclosed |
| WO-1997020000-A2 | IMPROVED COLORANT STABILIZERS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1997-06-05 | — | — | WO | disclosed |
| US-5616443-A | TONER FOR ELECTROGRAPHY | KIMBERLY-CLARK CORPORATION (US) | 1997-04-01 | — | — | US | disclosed |
| WO-1996022335-A1 | NOVEL COLORANTS AND COLORANT MODIFIERS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1996-07-25 | — | — | WO | disclosed |
| WO-1996019502-A1 | IMPROVED MUTABLE COMPOSITION | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1996-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213444-A1 | COMPOSITION FOR ENHANCING KERATIN FIBERS | KRT18, DSG1, CUTA | MAOA 1467/4885MAOB 2811/4885LRRK2 4239/4885 |
| US-20240415751-A1 | WATER REDUCED COMPACT SHAMPOO COMPOSITION | PSAP, POLR1C, AQP3 | MAOA 2355/4885MAOB 2873/4885LRRK2 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.